HCG — Home Capital Income Statement
0.000.00%
FinancialsBalancedMid Cap
- CA$1.69bn
- CA$5.45bn
- CA$497.06m
Annual income statement for Home Capital, fiscal year end - December 31st, CAD millions except per share, conversion factor applied.
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Interest Income | |||||
| Interest Expense | |||||
| Net Interest Income | 352 | 402 | 475 | 493 | 439 |
| Loan Loss Provision | |||||
| Net Interest Income After Loan Loss Provision | 332 | 382 | 441 | 526 | 419 |
| Non Interest Income | |||||
| Non Interest Expense | |||||
| Net Income Before Taxes | 180 | 185 | 239 | 334 | 207 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 133 | 136 | 176 | 245 | 150 |
| Net Income Before Extraordinary Items | |||||
| Net Income | 133 | 136 | 176 | 245 | 150 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Dilution Adjustment | |||||
| Diluted Net Income | 133 | 136 | 176 | 245 | 150 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 1.65 | 2.29 | 3.33 | 4.78 | 3.76 |
| Dividends per Share |